ArriVent COO exercises options for 40,693 shares
The reported option counts and exercise prices reflect the 15.21-for-1 reverse stock split effected January 23, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ArriVent BioPharma, Inc. Chief Operating Officer Robin LaChapelle exercised stock options covering 40,693 common shares on October 30, 2026, at exercise prices of $2.2815, $3.6504 and $6.2361 per share. The MAKS Yao Trust is listed with an indirect holding of 394,477 shares; LaChapelle is its trustee.
Insider Trade Summary
40,693 shares exercised/converted
Exercise
10 txns
Insider
LaChapelle Robin
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F2, F3 | 410 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F2, F4 | 4,550 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F2, F4 | 1,820 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F2, F5 | 16,265 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F2, F6 | 17,648 | $0.00 | $0.00 |
| Exercise | Common Stock | 16,265 | $3.6504 | $59K |
| Exercise | Common Stock | 410 | $2.2815 | $935.42 |
| Exercise | Common Stock | 4,550 | $2.2815 | $10K |
| Exercise | Common Stock | 1,820 | $2.2815 | $4K |
| Exercise | Common Stock | 17,648 | $6.2361 | $110K |
| Holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 41,423 contracts (Direct);
Common Stock — 176,429 shares (Direct);
Common Stock — 394,477 shares (Indirect, by Trust)
Footnotes (6)
- F1. The Reporting Person is the Trustee of The MAKS Yao Trust and may be deemed to have shared voting and investment power over the shares held by The MAKS Yao Trust. The Reporting Person does not have a pecuniary interest in and disclaims beneficial ownership of the shares held by The MAKS Yao Trust.
- F2. Reflects the 15.21-for-1 reverse stock split of the Issuer's common stock effected on January 23, 2024 in connection with the Issuer's initial public offering, pursuant to which (i) the number of shares of common stock underlying the option was divided by 15.21 and (ii) the exercise price of the option was multiplied by 15.21.
- F3. The shares underlying this option vested as to 25% on September 8, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- F4. The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- F5. The shares underlying this option vested as to 25% on February 1, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- F6. The shares underlying this option vested as to 25% on August 22, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Shares covered by option exercises: 40,693 shares
Exercise price: $2.2815 per share
Exercise price: $3.6504 per share
+2 more
5 metrics
Shares covered by option exercises
40,693 shares
October 30, 2026
Exercise price
$2.2815 per share
Reported option exercises on October 30, 2026
Exercise price
$3.6504 per share
Reported option exercise on October 30, 2026
Exercise price
$6.2361 per share
Reported option exercise on October 30, 2026
Trust shareholding
394,477 shares
Indirect holding by The MAKS Yao Trust
Key Terms
reverse stock split, exercise price, vesting, pecuniary interest, +1 more
5 terms
reverse stock split financial
"15.21-for-1 reverse stock split of the Issuer's common stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
exercise price financial
"exercise price of the option was multiplied by 15.21"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"remainder vesting in 36 equal monthly installments thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
pecuniary interest regulatory
"does not have a pecuniary interest in"
beneficial ownership regulatory
"disclaims beneficial ownership of the shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
